ReviewClinical pharmacology and therapeutics2021

Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.

Hugo M Vargas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.